Tg Therapeutics (TGTX) Gross Margin (2021 - 2026)
Tg Therapeutics (TGTX) posted Gross Margin of 82.86% for Q2 2026, down 3.72 percentage points from 86.58% a year earlier and down 0.79 percentage points from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Gross Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Tg Therapeutics was 82.37%, down 4.59 percentage points year-over-year; for FY2025, it was 83.66%, down 4.64 percentage points from FY2024.
- Annual Gross Margin shows a four-year change of -4.53 percentage points (FY2021 to FY2025).
- In prior years, Tg Therapeutics' Gross Margin was 88.30% in FY2024 (-5.65 pp), 93.95% in FY2023 (+3.47 pp), 90.48% in FY2022 (+2.30 pp) and 88.19% in FY2021.
- Quarterly Gross Margin has run from a low of 80.19% in Q4 2025 to a high of 97.88% in Q3 2023 over five years.
- On a year-over-year basis, Gross Margin has declined in each of the last six quarters, with an average year-over-year change of -3.85 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2024, with a gain of 3.63 percentage points; the weakest was Q4 2023, with a drop of 14.11 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 83.65% (Q1 2026), 80.19% (Q4 2025) and 82.63% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | Tg Therapeutics | 8.60 Bn | 7.99 Bn | 199.14 Mn | 82.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.86% |
| Mar 31, 2026 | 83.65% |
| Dec 31, 2025 | 80.19% |
| Sep 30, 2025 | 82.63% |
| Jun 30, 2025 | 86.58% |
| Mar 31, 2025 | 87.14% |
| Dec 31, 2024 | 85.77% |
| Sep 30, 2024 | 88.86% |
| Jun 30, 2024 | 88.70% |
| Mar 31, 2024 | 91.43% |
| Dec 31, 2023 | 82.14% |
| Sep 30, 2023 | 97.88% |
| Jun 30, 2023 | 88.11% |
| Mar 31, 2023 | 89.02% |
| Dec 31, 2022 | 96.25% |
| Sep 30, 2022 | 97.87% |
| Mar 31, 2021 | 82.47% |
API Access
Tg Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();